VUNO Inc.

We are on a mission to “View the Invisible, Know the Unknown”, and have goals to suggest optimal treatments to medical practitioners and to find biomarkers that help to develop the treatment.

Medical Imaging

CT/X-ray/MR/Non-Radiolog

Lesion detection and quantification

Abnormality Screening

Treatment response prediction

Pathology

Digital pathology slides

Slide quantification for predictive biomarker

Cancerous cell detection

Biosignals

ECG, Vital Sign

Patient Monitoring

Quantification of disease risk

Early warning of adverse event

Speech

Medical Dictation

  • VUNO in Numbers

    VUNO
    in Numbers

  • VUNO Med®-BoneAge™, the first MFDS-approved medical AI device in Korea

    9th

    MFDS approval and PMDA/CE Certifieds

    0+

    Successes in developing & commercializing AI-based medical solutions

    0+

    Patents (Korea & Globe) in AI core technology, assisting diagnosis, and disease detection

    0+

    Patents (Korea & Globe) in AI core technology, assisting diagnosis, and disease detectio

    0+

    Experts dedicated to medical AI R&D

    0+

    Concentration in R&D workforce

    0%+

    R&D partnerships with a variety of hospitals and research centers in home and abroad

    0+